Fund Holdings — SILVERARC CAPITAL MANAGEMENT, LLC

Total Portfolio Value:
$356.62M
Total Bought:
$124.74M
Total Sold:
$142.15M
Net Transaction:
-$17.41M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Merus N V645,581566,287-79,294$17.75M$25.50M7.15%+$7.75M
Solid Biosciences Inc594,8551,325,065+730,210$3.65M$17.65M4.95%+$14.00M
Morphic Hldg Inc500,042483,972-16,070$14.44M$17.04M4.78%+$2.59M
ORIC Pharmaceuticals, Inc.(ORIC)1,170,0001,113,007-56,993$10.76M$15.30M4.29%+$4.54M
Mersana Therapeutics Inc6,420,1362,968,798-3,451,338$14.89M$13.30M3.73%-$1.59M
Celldex Therapeutics, Inc.(CLDX)247,215299,316+52,101$9.80M$12.56M3.52%+$2.76M
Avidity Biosciences Inc0489,303+489,303$0$12.49M3.50%+$12.49M
Nuvalent Inc193,000157,750-35,250$14.20M$11.85M3.32%-$2.36M
C4 Therapeutics, Inc.(CCCC)01,435,931+1,435,931$0$11.73M3.29%+$11.73M
Praxis Precision Medicines, Inc.(PRAX)283,841190,556-93,285$6.32M$11.63M3.26%+$5.30M
Poseida Therapeutics Inc3,705,7793,596,476-109,303$12.45M$11.47M3.22%-$978.7K
Akero Therapeutics Inc249,254399,949+150,695$5.82M$10.10M2.83%+$4.28M
Perspective Therapeutics, Inc.(CATX)08,108,108+8,108,108$0$9.65M2.71%+$9.65M
Rhythm Pharmaceuticals, Inc.(RYTM)174,248183,776+9,528$8.01M$7.96M2.23%-$47.2K
Alpine Immune Sciences Inc297,789199,020-98,769$5.68M$7.89M2.21%+$2.21M
UroGen Pharma Ltd.(URGN)525,404508,587-16,817$7.88M$7.63M2.14%-$252.3K
Gossamer Bio, Inc.(GOSS)6,130,2686,130,2680$5.59M$7.23M2.03%+$1.64M
MacroGenics, Inc.(MGNX)1,258,641478,079-780,562$12.11M$7.04M1.97%-$5.07M
Cogent Biosciences, Inc.(COGT)966,7481,036,667+69,919$5.68M$6.97M1.95%+$1.28M
Kalvista Pharmaceuticals Inc111,734561,183+449,449$1.37M$6.66M1.87%+$5.29M
Kodiak Sciences Inc.(KOD)1,000,0001,238,822+238,822$3.04M$6.52M1.83%+$3.48M
Veracyte, Inc.(VCYT)247,723280,773+33,050$6.81M$6.22M1.74%-$592.9K
Crinetics Pharmaceuticals In0127,835+127,835$0$5.98M1.68%+$5.98M
Olema Pharmaceuticals, Inc.(OLMA)573,830515,317-58,513$8.05M$5.83M1.64%-$2.22M
Helix Acquisition Corp IiCL A0500,000+500,000$0$5.20M1.46%+$5.20M
EyePoint, Inc.(EYPT)0247,968+247,968$0$5.13M1.44%+$5.13M
Boundless Bio, Inc.(BOLD)0312,500+312,500$0$4.45M1.25%+$4.45M
TELA Bio, Inc.(TELA)795,080776,851-18,229$5.26M$4.40M1.24%-$858.7K
Biogen Inc.(BIIB)20,00019,365-635$5.18M$4.18M1.17%-$999.7K
Fulcrum Therapeutics, Inc.(FULC)0398,436+398,436$0$3.76M1.05%+$3.76M
Scholar Rock Holding Corporation(SRRK)270,000199,415-70,585$5.08M$3.54M0.99%-$1.53M
Cytokinetics, Incorporated(CYTK)050,000+50,000$0$3.51M0.98%+$3.51M
Apogee Therapeutics Inc050,000+50,000$0$3.32M0.93%+$3.32M
Jasper Therapeutics, Inc.(JSPR)0109,892+109,892$0$3.23M0.90%+$3.23M
Insmed Incorporated(INSM)155,504113,616-41,888$4.82M$3.08M0.86%-$1.74M
Wave Life Sciences, Inc.SHS(WVE)0495,471+495,471$0$3.06M0.86%+$3.06M
Trevi Therapeutics, Inc.(TRVI)863,883844,235-19,648$1.16M$2.91M0.82%+$1.76M
Xenon Pharmaceuticals Inc.(XENE)163,16866,090-97,078$7.52M$2.85M0.80%-$4.67M
DexCom, Inc.(DXCM)31,00020,000-11,000$3.85M$2.77M0.78%-$1.07M
Cerus Corporation(CERS)1,499,8511,465,744-34,107$3.24M$2.77M0.78%-$469.4K
Pliant Therapeutics, Inc.(PLRX)318,524183,392-135,132$5.77M$2.73M0.77%-$3.04M
Rocket Pharmaceuticals, Inc.(RCKT)382,672101,002-281,670$11.47M$2.72M0.76%-$8.75M
Compugen Ltd.(CGEN)940,0001,000,000+60,000$1.86M$2.58M0.72%+$718.8K
Intra-Cellular Therapies Inc80,00034,807-45,193$5.73M$2.41M0.68%-$3.32M
Newamsterdam Pharma Company
ORDINARY SHARES
099,612+99,612$0$2.36M0.66%+$2.36M
Evogene LtdSHS3,100,0003,085,503-14,497$2.60M$2.31M0.65%-$289.9K
ADC Therapeutics SASHS(ADCT)0501,222+501,222$0$2.25M0.63%+$2.25M
Verona Pharma PlcADS0136,714+136,714$0$2.20M0.62%+$2.20M
Mirum Pharmaceuticals, Inc.(MIRM)80,81179,194-1,617$2.39M$1.99M0.56%-$396.2K
Krystal Biotech, Inc.(KRYS)010,000+10,000$0$1.78M0.50%+$1.78M
Modular Med Inc0900,000+900,000$0$1.67M0.47%+$1.67M
Terns Pharmaceuticals Inc516,999250,551-266,448$3.36M$1.64M0.46%-$1.71M
Viking Therapeutics, Inc.(VKTX)020,000+20,000$0$1.64M0.46%+$1.64M
Amylyx Pharmaceuticals, Inc.(AMLX)0500,000+500,000$0$1.42M0.40%+$1.42M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)031,980+31,980$0$1.25M0.35%+$1.25M
Fractyl Health, Inc.(GUTS)0166,666+166,666$0$1.23M0.35%+$1.23M
89bio Inc158,71992,298-66,421$1.77M$1.07M0.30%-$698.5K
ABIVAX Société AnonymeADS(ABVX)075,000+75,000$0$1.07M0.30%+$1.07M
Zura Bio LimitedCL A(ZURA)462,997328,504-134,493$2.16M$844.3K0.24%-$1.32M
Karyopharm Therapeutics Inc.(KPTI)561,955558,466-3,489$486.1K$843.3K0.24%+$357.2K
Geron Corporation(GERN)0250,000+250,000$0$825.0K0.23%+$825.0K
Molecular Templates Inc354,608354,6080$1.32M$794.3K0.22%-$528.4K
Adicet Bio Inc0331,279+331,279$0$778.5K0.22%+$778.5K
Mineralys Therapeutics, Inc.(MLYS)056,944+56,944$0$735.1K0.21%+$735.1K
Aligos Therapeutics Inc668,512655,515-12,997$443.9K$642.4K0.18%+$198.5K
Relmada Therapeutics, Inc.(RLMD)100,00099,379-621$414.0K$462.1K0.13%+$48.1K
Erasca, Inc.(ERAS)0223,845+223,845$0$461.1K0.13%+$461.1K
Structure Therapeutics IncADS010,000+10,000$0$428.6K0.12%+$428.6K
Rezolute, Inc.(RZLT)157,085151,985-5,100$155.9K$387.6K0.11%+$231.7K
Yarrow Bioscience Inc(YARW)086,383+86,383$0$265.2K0.07%+$265.2K
Elutia Inc.CL A(ELUT)078,580+78,580$0$247.5K0.07%+$247.5K
Immunome, Inc.(IMNM)07,489+7,489$0$184.8K0.05%+$184.8K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)104,828104,8280$51.4K$31.4K0.01%-$20.0K
Altimmune, Inc.EQUITIES(ALT)150,0000-150,000$1.69M$0—-$1.69M
Annexon, Inc.EQUITIES(ANNX)417,4290-417,429$1.90M$0—-$1.90M
Apellis Pharmaceuticals IncEQUITIES
COM
10,0000-10,000$598.6K$0—-$598.6K
BioCryst Pharmaceuticals, Inc.EQUITIES(BCRX)248,7280-248,728$1.49M$0—-$1.49M
Biohaven Ltd.EQUITIES(BHVN)70,6950-70,695$3.03M$0—-$3.03M
Caribou Biosciences, Inc.EQUITIES(CRBU)900,8180-900,818$5.16M$0—-$5.16M
CymaBay Therapeutics IncEQUITIES218,9750-218,975$5.17M$0—-$5.17M
Immunovant, Inc.EQUITIES(IMVT)20,0000-20,000$842.6K$0—-$842.6K
Intellia Therapeutics, Inc.EQUITIES(NTLA)54,8220-54,822$1.67M$0—-$1.67M
Intuitive Surgical, Inc.EQUITIES(ISRG)15,8080-15,808$5.33M$0—-$5.33M
Medtronic plcEQUITIES(MDT)135,0000-135,000$11.12M$0—-$11.12M
MoonLake ImmunotherapeuticsEQUITIES(MLTX)50,0000-50,000$3.02M$0—-$3.02M
Penumbra, Inc.EQUITIES(PEN)20,0000-20,000$5.03M$0—-$5.03M
PMV Pharmaceuticals, Inc.EQUITIES(PMVP)550,0000-550,000$1.71M$0—-$1.71M
SanofiEQUITIES(SNY)220,0000-220,000$10.94M$0—-$10.94M
Sarepta Therapeutics, Inc.EQUITIES(SRPT)46,8840-46,884$4.52M$0—-$4.52M
Schrödinger, Inc.EQUITIES(SDGR)31,1170-31,117$1.11M$0—-$1.11M
Soleno Therapeutics IncEQUITIES73,6650-73,665$2.97M$0—-$2.97M
United Therapeutics CorporationEQUITIES(UTHR)16,3600-16,360$3.60M$0—-$3.60M
Viridian Therapeutics, Inc.EQUITIES(VRDN)50,4380-50,438$1.10M$0—-$1.10M
argenx SEEQUITIES(ARGX)4,8260-4,826$1.84M$0—-$1.84M
Page 1 of 1
SILVERARC CAPITAL MANAGEMENT, LLC — 13F Holdings — Q1 2024 | TickerTrail